Economic InsightEconomic InsightEconomic Insight
Notification Show More
Font ResizerAa
  • Home
  • Business News
  • Economics
  • Finance
  • Investment
  • Stock Market
  • Trading
Reading: RFK Jr.’s new ACIP CDC vaccine panel holds first meeting
Share
Font ResizerAa
Economic InsightEconomic Insight
  • About Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Contact
Search
  • Home
  • Business News
  • Economics
  • Finance
  • Investment
  • Stock Market
  • Trading
Have an existing account? Sign In
Follow US
© EconomicsInsight. All Rights Reserved.
Economic Insight > Blog > Stock Market > RFK Jr.’s new ACIP CDC vaccine panel holds first meeting
RFK Jr.’s new ACIP CDC vaccine panel holds first meeting
Stock Market

RFK Jr.’s new ACIP CDC vaccine panel holds first meeting

EC Team
Last updated: June 25, 2025 3:30 pm
EC Team
Published June 25, 2025
Share
SHARE

General views of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.

Tami Chapel | Reuters

A key government panel of vaccine advisors is holding its first meeting Wednesday since Health and Human Services Secretary Robert F. Kennedy Jr. appointed several vaccine critics to the group.

Earlier this month, Kennedy took a stunning step by replacing all members of the Advisory Committee on Vaccination Practices, or ACIP, to advise the Centers for Disease Control and Prevention. The group will review vaccine data and develop recommendations to determine who is eligible for the shot and whether the insurance company should cover them.

Given some of their skepticism about vaccination, it is unclear how new Kennedy members will affect US vaccine policy and availability.

“Not all vaccines are good or bad,” said Dr. Martin Kruldorf, a new ACIP chair, in his opening remarks.

“If you think that all vaccines are safe and effective and you want all of them, or that all vaccines are dangerous and you don’t want any of them, you’re not of much use to us.

“But if you want to know which vaccines are suitable for you and your child, and based on your age, we provide evidence-based recommendations,” he added.

between All day meeting On Wednesday in Atlanta, the panel will evaluate data on Covid-19 vaccines and RSV shots and vote for the latter recommendation. The group will re-convene on Thursday to see data on shots of the flu and other diseases.

CDC Directors must approve these recommendations in order to become official policy.

Kulldorff said ACIP will create a new workgroup. This is staff who review published data, review unpublished data, and develop recommended options to present it to the committee. He said one new workgroup will review childhood vaccine schedules and look at shots where another new vaccine schedule has not been covered by reviews for more than seven years.

The latter group can look at the universally recommended hepatitis B vaccine and ask whether it is “smart” to manage shots on all newborns before leaving the hospital, among other topics.

“This was supposed to be a regular ACIP practice, but it wasn’t done in a thorough and systematic way. It’s going to change that,” Kulldorff said.

What a new panel member said about the vaccine

ACIP members are independent medical and public experts who make recommendations based on rigorous scientific reviews and evidence. However, Kennedy’s eight new members include well-known vaccine critics, including Dr. Robert Malone.

Malone charges himself for playing an important role in creating the mRNA vaccine, but has gained great support for making unfounded, unfounded claims about the Covid-19 shot.

Another new member, Retsef Levi, pushed him to stop administering mRNA vaccines, and incorrectly claimed x’s post They “causing serious harm, including death, especially among young people.”

Another member, Vicki Pebworth, is a nurse on the National Vaccine Information Center’s board of directors. The organization has been widely criticized as the main source of misinformation and fear about vaccinations.

At a meeting Wednesday, Pebworth revealed that she owns funds for the stock and health sector, including vaccine makers. However, she said her holdings could be attended at the ACIP meeting under an amount the government considers to be a conflict of interest.

Kennedy fired a former ACIP member for having what he called a “lasting conflict of interest.” However, all HHS agencies and their advisory panels have strict policies for conflicts of interest and have not had any related issues for many years.

You Might Also Like

Want to earn passive income from a Stocks and Shares ISA? Here’s how

B2Gold Announces Voting Results from its 2025 Annual General and Special Meeting

Iran threatens ‘irreparable damage’ if U.S. enters Israel conflict

WORK Medical Technology Group LTD Soars on $5M Offering: Unpacking the Hype

Palantir Stock: What The Bears Keep Missing (NASDAQ:PLTR)

TAGGED:ACIPCDCholdsJr.sMeetingpanelRFKvaccine
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Popular News
The Infinite Money Loop
Investment

The Infinite Money Loop

EC Team
EC Team
April 18, 2025
India Accelerates Brahmos-II Development: Next-generation hypersonic missile set to reach Mach 7 speed
My Weekly Reading for May 25, 2025
Newmont Announces a Decrease in its Holdings of Discovery Silver Corp.
Trump’s Tussle With Powell, Big Tech’s Parade Funding, Trump Card Visa And More: This Week In Politics
- Advertisement -
Ad imageAd image

Categories / Tags

  • Business News
  • Finance
  • Investment
  • Economics
  • Stock Market
  • Trading
  • stock
  • Stocks
  • Trading
  • Trump

About US

Founded with the belief that economic understanding should be accessible to all, we strive to decode complex market movements, break down financial trends, and spotlight business developments that matter — all in a clear, digestible format.
Quick Link
  • Home
  • Blog
  • Contact
Important Links
  • About Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Contact

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

© EconomicsInsight. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?